BOQI International Medical Inc. Enters into MOU with Chongqing Cogmer Biology Technology Co., Ltd
November 09 2020 - 8:30AM
BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the
“Company”) today announces the signing of a Memorandum of
Understanding (MoU) with Chongqing Cogmer Biology Technology Co.,
Ltd (“Cogmer Biology”) on October 28, 2020.
Pursuant to the MOU, BOQI International Medical Inc. and
Chongqing Cogmer Biology Technology Co., Ltd agreed to move forward
on four stages of work, including completing all relevant
assessment and audit of Cogmer Biology, completing on-site audit
and evaluation of Cogmer Biology, signing a Stock Purchase
Agreement based on the audit and evaluation result, and completing
the relevant business procedures for the transaction.
Chongqing Cogmer Biology Technology Co. Ltd is a modern
technology company that provides comprehensive solutions for
medical laboratories in hospitals and clinics. Cogmer Biology is
mainly engaged in the sales of medical equipment and in vitro
diagnostic (IVD) reagents, including immunofluorescence analyzer,
chemiluminescence immunoassay analyzer, automatic hematology
analyzer, and fully automatic biochemistry analyzer. At present,
Cogmer Biology has 100+ cooperative manufacturers, 200+
distribution partners, and 500+ direct customers.
“Cogmer Biology is one of our existing customers who has
purchased over $10 million of our medical devices. It has
professional laboratory technicians and consultants, and provided
hospitals with advanced medical devices to improve the quality of
medical care. Both Cogmer Biology and BIMI have the good
will to enhance the positive relations and to deepen
cooperation on the wholesale medical devices business,” said Tiewei
Song, Chief Executive Officer and President of BOQI International
Medical Inc.
About BOQI International Medical Inc. BOQI International
Medical Inc. (formerly known as NF Energy Saving Corporation)
(NASDAQ: BIMI) was founded in 2006. In February 2019, the Board of
Directors of the company was reorganized with a focus on the health
industry. The Company is now exclusively a healthcare products
provider, offering a broad range of healthcare products and related
services. For more information about BOQI International Medical,
please visit www.usbimi.com.
Safe Harbor Statement Certain matters discussed in this
news release are forward-looking statements that involve a number
of risks and uncertainties including, but not limited to, the
Company’s ability to achieve profitable operations, its ability to
continue to operate as a going concern, its ability to continue to
meet NASDAQ continued listing requirements, the effects of the
spread of the Coronavirus (COVID-19), the demand for the Company’s
products and the Company’s customers’ economic condition,
risk of operations in the People’s Republic of China, general
economic conditions and other risk factors detailed in the
Company’s annual report and other filings with the United States
Securities and Exchange Commission. Investors are urged to read the
Company’s Quarterly Report on Form 10-Q for the three months ended
March 31, 2020 for further information about the Company’s
financial results, liquidity and capital resources.
IR Contact: Dragon Gate Investment Partners LLC Tel:
+1(646)-801-2803 Email:
BIMI@dgipl.com
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Apr 2023 to Apr 2024